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ABSTRACT
Background: Surgery in patients with sickle cell disease
is associated with high morbidity. To reduce this high
morbidity, different preoperative transfusion regimens
were introduced. However, blood transfusion is associ-
ated with problems. This prospective study aims to estab-
lish the safety of conducting laparoscopic cholecystec-
tomy without transfusion in sickle cell disease patients.
Methods: Forty patients (16 males and 24 females; mean
age 26.6 years) undergoing laparoscopic cholecystectomy
for cholelithiasis were divided into 2 matched groups:
Group I “no transfusion” (n24 patients; 60%) and Group
II “transfusion” (n16; 40%). In Group II, 9 patients
(22.5%) received a simple transfusion and 7 (17.5%) a
partial exchange transfusion.
Results: Group II patients had significantly higher levels
of Hb-S prior to transfusion. They developed a signifi-
cantly higher complication rate (25% vs. 0%) and subse-
quently longer hospital stay (3.92 vs. 2.11.4). More-
over, there was no significant difference in the complications
between the simple transfusion and partial exchange trans-
fusion subgroups.
Conclusion: Surgery in SCD patients is safe without a
preoperative blood transfusion. Moreover, preoperative
blood transfusion is associated with significantly higher
postoperative complications and longer hospital stay.
Hence, a “no transfusion” policy is recommended.
Key Words: Sickle cell disease, Surgery, Postoperative
complications, Blood transfusion.
INTRODUCTION
Sickle cell disease (SCD), the most common inherited hema-
tological disease affecting man, is prevalent in the Arabian
Gulf countries. The disease is characterized by red cells
undergoing sickling due to polymerization of sickle hemo-
globin (Hb-S) when deoxygenated, with subsequent loss of
flexibility and repeated hemolysis with microvascular occlu-
sion.1 The susceptibility of red cells to sickling correlates well
with the concentration of abnormal Hb-S, which results from
substitution of valine for glutamic acid in position 6 of the
beta-globin chain.1 This state of chronic hemolysis leads to
an increased risk of gallstone formation, with a prevalence
ranging from 30% to 70%.2–6
Patients with SCD have a higher incidence of postopera-
tive morbidity and mortality than patients without hema-
tologic abnormalities7–13; the risk of postoperative compli-
cations in SCD patients ranges from 7% to 32%.14
Preoperative transfusion appears to reduce morbidity and
mortality associated with surgery in SCD patients.2,3,4,13
However, a less aggressive transfusion regimen has been
successfully practiced7,8,15 and does not carry a greater
risk of postoperative complications than aggressive trans-
fusion carries.12 Furthermore, a large United States obser-
vational study10 demonstrated a similar rate of complica-
tions in both transfused and nontransfused patients
undergoing cholecystectomy, and nonrandomized stud-
ies11 have shown lower complication rates in nontrans-
fused SCD patients undergoing minor procedures.
The Eastern province of Saudi Arabia has a large local
population of patients with SCD. Hence, since 2006 we
have used a standardized approach to the perioperative
management of SCD patients undergoing laparoscopic
cholecystectomy (LC). This study aims at evaluating the
perioperative complications and postoperative course of
SCD patients undergoing elective LC with or without peri-
operative blood transfusion.
MATERIALS AND METHODS
From January 2006 to December 2009, all SCD patients
who underwent LC for symptomatic gallstones were pro-
spectively included in the study. Patients were divided
into 2 groups: Group I was given no transfusion and
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SCIENTIFIC PAPERGroup II received a preoperative blood transfusion (sim-
ple or partial exchange transfusion). All patients under-
went a standardized perioperative management protocol.
In brief, all patients were seen in the pre-anesthetic clinic
for preoperative evaluation and preparation and admitted
1 day to 2 days before the planned operation for adequate
hydration and blood transfusion if it was indicated. Pa-
tients with hemoglobin of 10g/dL were not transfused. If
hemoglobin was 10g/dL, simple blood transfusion with
packed red cells was given regardless of Hb-S percentage.
Partial exchange transfusion was given only to patients
who were considered to have severe SCD based on very
high Hb-S, a history of frequent hospital and ICU admis-
sions with sickling crises, and the presence of sickle-
related systemic complications. Blood transfusion was
usually given 1 day to 2 days before LC. All patients were
adequately hydrated the night before the operation
through an intravenous line set up in the general surgical
ward. Prophylactic antibiotics (one dose of first-genera-
tion cephalosporins) were given intravenously with the
induction of anesthesia, and an experienced laparoscopic
surgeon conducted the surgery. The operative time was
estimated from the start of anesthesia until application of
dressings. Patients were nursed postoperatively in a gen-
eral surgical ward and were kept warm, well oxygenated,
pain-free, and well hydrated. Incentive spirometry was
used in all patients. Early ambulation to guard against
DVT was encouraged, and patients were discharged home
once fully ambulant and without any postoperative com-
plications. Postoperative complications were closely mon-
itored and recorded.
Statistical Analysis
Data are presented as mean  SD and range where appro-
priate. Comparisons between groups were made by using
Fisher’s exact test, and the one-way ANOVA test. Values of
P.05 were considered statistically significant. All statistical
analyses were conducted using SPSS version 16 software.
RESULTS
During the study period, 40 patients (16 males and 24
females) with SCD underwent LC for symptomatic gall-
stones. The mean age was 26.6 years (range, 6 to 53).
Twenty-three had sickling crises, ranging from 1 to 9
(mean, 3.5) episodes per year. Twenty-four (60%) patients
received no transfusion (Group I), and 16 (40%) patients
were given preoperative blood transfusions (Group II); 9
(22.5%) received a simple transfusion, and 7 (17.5%) re-
ceived a partial exchange transfusion. The mean preop-
erative hemoglobin, fetal hemoglobin (Hb-F), and Hb-S
for both groups are shown in Table 1. Both groups were
comparable with no significant difference in age, male to
Table 1.
Comparative Parameters Between the 2 Groups
Parameter
a Group I Group II P Value
b
No transfusion Transfused group
Number of patients 24 16
Age (MeanSD) (years) 26.713.5 26.512.5 .96
No. of males 8 10 .07
No. of females 16 6 .07
Preoperative Hb (mean SD) 10.81.1 9.21.4 .001
Hb-F (mean SD) 11.713.7 13.28.2 .7
Hb-S (mean SD) 50.622.8 74.910.4 .005
Operation time 102.533 10345 .9
(mean SD)
No. of conversion (%) 1 (4.2) 1 (6.25) .8
Postoperative complications 0 (0) 5 (31.25) .02
Postoperative hospital stay (mean SD) 2.11.4 3.92 .002
aHbhemoglobin; Hb-Ffetal hemoglobin; Hb-Ssickle hemoglobin; SDstandard deviation.
bP.05; Values .05 are significant.
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tients had significantly lower mean preoperative hemo-
globin and higher levels of Hb-S prior to transfusion.
Group II patients developed a significantly higher com-
plication rate (31.25% vs. 0%) and subsequently longer
hospital stay (3.9  SD 2 vs. 2.1  SD 1.4). Moreover, no
significant difference existed in the complications be-
tween the simple transfusion and partial exchange trans-
fusion subgroups.
Two cases (5%) were converted to open, one in each
group. One was due to uncontrollable bleeding during
simultaneous splenectomy, and the other was due to
dense adhesions in a patient with empyema of the gall-
bladder.
Postoperative Complications
There were 5 (12.5%) postoperative complications; all
occurred in Group II patients who received blood trans-
fusions (P.05) (Figure 1). There were 3 mild vasooc-
clusive crises (VOC); one patient needed ICU admission
for postoperative hypotension (a case of combined LC
and splenectomy converted to open due to bleeding),
one patient had bronchopneumonia, and one had acute
chest syndrome (ACS) and was admitted 2 days after
discharge and treated conservatively. No correlation
was found between the level of Hb-S and the incidence
of complications. Table 2 shows the relation of com-
plications to various parameters. Complications were
significant in the transfused Group II (P.007), very
close to significance for the Age group 30 years
(P.05), and close to significance for the number of
crises, but insignificant for preoperative Hb-S, mean
preoperative hemoglobin, and the operative time. The
mean postoperative hospital stay was 2.8 days (range, 1
to 8). It was significantly longer for Group II as a result
of the higher complication rate.
DISCUSSION
This study was conducted as a pilot without random-
ization to see if surgery in SCD patients without preop-
erative blood transfusion is safe. Blood transfusion is
commonly used in the comprehensive management of
SCD patients. However, it is not without risk of trans-
fusion-related complications, such as alloimmunization
(17% to 30%),14 delayed hemolytic transfusion reac-
tion,16 and hyperhemolysis.17 Therefore, the current
advice is to decrease exposure to blood products if at
all possible.15 Several preoperative transfusion regi-
mens have been used to reduce the risk of periopera-
tive complications in patients with SCD. They include
simple and exchange transfusions before LC. However,
at present there is no consensus regarding the value of
a preoperative transfusion in these patients.9,12,15,18–20
Exchange transfusion is given to lower the level of
Hb-S, usually to 30%, or a simple transfusion of 1 or 2
units of blood to raise the overall hemoglobin level to
approximately 10g/dL21 to improve the overall oxygen-
carrying capacity. In addition, by lowering the level of
Hb-S and the number of sickled red blood cells, whole
blood viscosity may fall, reducing the risk of VOC.22 In
our study, we have adopted 3 practices for blood trans-
fusion in SCD patients who are undergoing surgery.
The majority (60%) had their surgery without any form
of transfusion, while the remaining 40% had preopera-
tive transfusion in the form of either a simple transfu-
sion (22.5%) or a partial exchange transfusion (17.5%).
Simple “top up” is considered much safer than partial
exchange transfusion, and its use has been advocated.
It is interesting to find in this study a lack of correlation
between the level of Hb-S and the incidence of com-
plications. Such a finding may prompt the conduction
of a larger prospective randomized trial. Although clin-
ical and laboratory evidence is available that supports
the beneficial effects of dilution of sickle cells on out-
come,23–26 it is not certain if there is a threshold for such
effects or if the effects are proportionate to the percent-
age of Hb-S. Also, in this study, there were 5 (12.5%)
postoperative complications, all of which occurred in
Group II that received blood transfusion with no com-
plication in the larger nontransfused Group I (P.05).
Moreover, there was no significant difference in the
complications between the simple transfusion and par-
tial exchange transfusion subgroups.
Figure 1. Complications in no blood transfusion group (Group
I) and transfused (simple or exchange) group (Group II). TF 
transfusion group; Comp  complications; VOC  vasooclusive
crisis; ACS  acute chest syndrome.
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who showed no improved prophylactic benefit from an
aggressive transfusion regimen compared with conserva-
tive transfusion regimen, Haberkern et al9 reported that
vaso-occlusive pain episodes were highest in the non-
transfused group (mean preoperative Hb-S, 88%) and
lowest in the aggressive transfusion group patients (Hb-S,
34%), which may suggest a threshold of Hb-S percentage
at which vaso-occlusive events are more likely to occur.
Many centers, however, have adopted a more conserva-
tive policy following the publication of the study by the
preoperative transfusion in the SCD group,12 which
showed that simple “top up” transfusion was as safe as
aggressive exchange transfusion. Also, a recent national
survey of practices in the United Kingdom demonstrated
no difference in the rate of postoperative complications in
patients who received a transfusion and those who did
not, suggesting a growing trend in the United Kingdom to
avoid transfusion when possible.15
Some centers, like ours, do not routinely transfuse patients
before surgery but rely heavily on the delivery of com-
prehensive care by a multidisciplinary team to prevent the
development of postoperative sickle cell events.8 A retro-
spective observational study8 that examined outcomes in
SCD children undergoing 66 surgical procedures without
preoperative transfusion showed only one episode of ACS
and no pain crises after 46 minor procedures. It was
therefore concluded that any potential benefit from trans-
fusion was low, and the risks of transfusion outweigh the
benefits. Hence, transfusion is not justified for minor pro-
cedures.8 Also Leff et al20 demonstrated that LC can be
performed safely in SCD patients without preoperative
transfusion even in patients with hemoglobin levels just
above 6g/dL before the operation. In a study that included
369 participants in Saudi Arabia, no advantage was dem-
onstrated for preoperative transfusion over no transfusion
in terms of reduced sickle-related complications, periop-
erative infection, and transfusion-related complications.27
No major complications were reported in either the trans-
fusion or no-transfusion groups, but significantly more
overall complications occurred in participants receiving
transfusion.27 This argues against routine preoperative
blood transfusion in SCD patients who are undergoing
surgery.
Transfusions are undertaken less frequently in countries
such as Jamaica than in North America, and interestingly,
Table 2.
Relations Between Complications and Various Parameters
Parameters Complication P Value
No (%) Yes (%)
Blood transfusion No 24 (60) 0 (0) .007
Yes 16 (30) 5 (100)
Age 30 24 (68.6) 1 (20) .05
30 11 (31.4) 4 (80)
Sex Male 15 (42.9) 2 (42.5) 1.00
Female 20 (57.1) 3 (60)
Number of crisis/year 5 28 (80) 2 (40) .09
5 7 (20) 3 (60)
Preoperative Hb
Group I Mean  SD 10.8 1.1 0 .82
Group II Mean  SD 9.171.56 9.361.49
Hb-S 50 13 (37.1) 0 (0) .15
50 22 (62.9) 5 (100)
Operative time 2 h 20 (57.1) 4 (80) .60
2 h 15 (42.9) 1 (20)
aHbhemoglobin; Hb-Ssickle hemoglobin; SDstandard deviation.
bP.05 is significant.
JSLS (2011)15:480–485 483observational studies do not report significantly increased
morbidity or mortality in operations without transfu-
sion.28,29 Whether this is due to the setting or clinical
differences is unclear. Indeed, the demand for blood
transfusions is likely to decline with the introduction of
alternative treatments, less invasive surgical techniques
like laparoscopic surgery with advanced high-energy de-
vices, and improved anesthetic agents. However, more
sound evidence in the form of well-run, multi-center,
randomized controlled studies is required to optimize the
clinical management regimen for these people.
CONCLUSION
LC can be performed safely without blood transfusion and
with no complications. Simple blood transfusion is re-
served for patients with hemoglobin 10g/dL who are
undergoing major surgery. Transfusion should be avoided
in any patient who is undergoing a minor surgical proce-
dure even if preoperative hemoglobin is 10g/dL. Peri-
operative management pays attention to preventing fac-
tors that trigger VOC and ACS, eg, dehydration, acidosis,
hypothermia, and infection, by keeping the patient warm,
well hydrated, well oxygenated, and pain-free in the peri-
operative period. The use of pneumatic compression de-
vices, incentive spirometry, and encouragement of early
mobilization are also important. We believe this practice is
responsible for the low rate of complications in this study.
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